Related Articles
Tumor microenvironment contributes to Epstein-Barr virus anti-nuclear antigen-1 antibody production in nasopharyngeal carcinoma
Novel ELISA for serodiagnosis of nasopharyngeal carcinoma based on a B cell epitope of Epstein‑Barr virus latent membrane protein 2
Epstein‑Barr virus infection mediated TP53 and Bcl‑2 expression in nasopharyngeal carcinoma pathogenesis
Nasopharyngeal carcinoma: A review of current updates
Association of Epstein-Barr virus with tumor cell proliferation: Clinical implication in nasopharyngeal carcinoma